Trajan Group Holdings Ltd (trj) Logo

Trajan Group Holdings Ltd (TRJ)

___:___ · Healthcare

TRJ Chart


TRJ's Principal Activity is the global developer and manufacturer of analytical and life sciences products and devices

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume (4w avg)
Day Range -
Prev Close
Last Trade


1 Week
1 Month
2022 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -4.89%


Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 579 of 2,420
Sector Rank 35 of 210

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies SPL / PSQ / RAC
EPS $0.047
DPS $0.00
Book Value Per Share $0.51

Broker Consensus

TRJ is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.


Date Heading Pages File Size Time

Corporate Overview

Trajan Group Holdings Limited (TRJ) is a global developer and manufacturer of analytical and life sciences products and devices founded to have a positive impact on human wellbeing through scientific measurement. Trajan is a global organisation of more than 520 people, with six manufacturing sites across the US, Australia, Europe and Malaysia, and operations in Australia, the US, Asia, and Europe.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office Ringwood VIC 3134
Registry Computershare
Auditor RSM Australia Partners
Date Listed 7 Jun 2021

Upcoming Calendar (Forecasted)

Date Event
24/08/2022 Report (Prelim)
24/08/2022 Report (Annual)
23/02/2023 Report (Interim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Mr Mark Andrew Licciardo Joint Company Secretary Jun 2021
Mr Alister John Hodges Chief Financial Officer,Joint Company Secretary Jun 2021
Mr John Anthony Eales Non-Executive Chairman,Non-Executive Director Mar 2021

Mr John Anthony Eales

Non-Executive Chairman,Non-Executive Director

Mr Eales has served as an executive, adviser, director and investor in a number of listed public companies and unlisted private organisations. He co-founded the Mettle Group in 2003 - a corporate consultancy which was acquired by Chandler Macleod in 2007. He has been a regular columnist in both the Australian Financial Review and The Australian over the last 20 years and is the author of two books, Learning from Legends Sport and Learning from Legends Business. He is the Chair of the World Rugby Hall of Fame Selection Panel and on the Rugby Australia Bid Advisory Board for the Rugby World Cup 2027. He was made a Member of the Order of Australia in 1999 for services to the community and rugby and is a Patron of the Melanoma Foundation, Hearts in Union and the Champagnat Trust.

Ms Sara Elizabeth Watts Non-Executive Director Mar 2021

Ms Sara Elizabeth Watts

Non-Executive Director

Ms Watts is an experienced Non-Executive Director with financial and operational experience across more than 20 years in a range of industries including technology, education, NFP and resources. Her previous executive positions include Chief Financial Officer of IBM Australia/New Zealand, Head of Internal Audit for IBM Asia Pacific and Vice-Principal (Operations) at the University of Sydney.

Mr Rohit Khanna Non-Executive Director Mar 2021

Mr Rohit Khanna

Non-Executive Director

Dr Khanna has nearly 40 years of experience in analytical science, business leadership and laboratory application software. In 1981, Dr Khanna co-founded Dynamic Solutions, a software-engineering firm dedicated to providing computing solutions to the scientific and engineering community. The company's data management software became a leader in transitioning the analytical instrument industry to automated system control and data analysis, before being acquired by Waters Corporation in 1986. Dr Khanna went on to hold various senior management roles at Waters Corporation, including Vice-President and General Manager of the Data Products Group. In 2002, Dr Khanna was appointed Vice-President, Worldwide Marketing, and most recently Dr Khanna was Senior Vice President of several key Waters Corporation businesses including Informatics, Service, and Chemistry - along with being a member of the Corporate Executive Committee. Dr Khanna retired from Waters Corporation at the end of 2017 but remains closely connected to the industry, participating on several Boards and providing strategic advisory services.

Ms Tiffiny Jane Lewin Non-Executive Director Mar 2021

Ms Tiffiny Jane Lewin

Non-Executive Director

Ms Lewin brings operational, risk and strategy expertise gained over a 30-year career spanning consumer goods, manufacturing, professional services and the finance sectors. Ms Lewin is currently a senior leader at Westpac Group where she has served since 2015. Prior to Westpac, Mr Lewin held senior leadership, operational and strategy roles across Australia and Asia for global organisations including Nestle Australia, Nestle Japan, SCA Hygiene, Mondelez International and Procter & Gamble where she successfully delivered organisational transformation, performance turnaround and market growth across business and consumer sectors. Previously acted as a board advisor to Trajan

Mr Robert (Bob) John Lyon Head of Corporate Development and General Counsel,Executive Director Sep 2014

Mr Robert (Bob) John Lyon

Head of Corporate Development and General Counsel,Executive Director

Mr Lyon joined Trajan in 2013. Mr Lyon has global responsibility for the strategic growth of Trajan's business through mergers and acquisitions, licensing arrangements, and commercial relationships with Trajan's industry, academic, government and research partners in the scientific and medical sectors globally. As Trajan's General Counsel he also has responsibility for the negotiation and execution of Trajan's investments and transactions, as well as for its broader legal requirements. Prior to joining Trajan, Mr Lyon had a 15-year career in law including as a partner at Page Seager Lawyers before spending six years with KPMG Corporate Finance.

Mr Stephen Andrew Tomisich Chief Executive Officer,Managing Director Aug 2011

Mr Stephen Andrew Tomisich

Chief Executive Officer,Managing Director

Mr Tomisich co-founded Trajan in 2011. Mr Tomisich is responsible for the design and implementation of Trajan's strategic business plan and has led the negotiations of key customer and distribution agreements, the completion of Trajan's acquisitions and the establishment of Trajan's technological pipeline.

Alister Hodges Chief Financial Officer N/A
Nigel Gilligan Chief Operations Officer N/A
Dr Andrew Gooley Chief Scientific Officer N/A
Sam Evans Senior Vice President Business Development N/A

Director Transactions

TRJ directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
05/04/22 Tiffiny Lewin Buy +12,269 $3.241 $39,759 On-market trade
28/03/22 Sara Watts Buy +3,164 $3.189 $10,089 On-market trade
18/10/21 John Eales Buy +58,824 $3.00 $176,472 Exercise of options
18/10/21 John Eales Exercise 58,824 $3.00 $176,472 Exercise of options

Director Interests

The current holdings of TRJ directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Tiffiny Lewin 05/04/2022 12,269 58,823 88,235 N/A
Sara Watts 28/03/2022 N/A 3,164 88,235 N/A
John Eales 18/10/2021 58,824 894,117 132,354 N/A
Stephen Tomisich 30/06/2021 N/A 76,470,588 N/A N/A
Rohit Khanna 30/06/2021 117,647 N/A 88,235 N/A
Robert (Bob) Lyon 30/06/2021 N/A 252,940 439,250 N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Aug 18, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Tomisich Family Pty Ltd <Tomisich Family A/C> 76,470,588 59.03%
J P Morgan Nominees Australia Pty Limited 12,355,571 9.54%
National Nominees Limited 8,933,866 6.90%
Citicorp Nominees Pty Limited 2,566,060 1.98%
Truebell Capital Pty Ltd <Truebell Investment Fund> 1,460,428 1.13%
BNP Paribas Nominees Pty Ltd <Agency Lending DRP A/C> 1,262,486 0.97%
UBS Nominees Pty Ltd 965,346 0.75%
HSBC Custody Nominees (Australia) Limited 960,263 0.74%
Ruck & Maul Pty Ltd <The John Eales Family A/C> 882,353 0.68%
Bnp Paribas Nominees Pty Ltd HUB24 Custodial Serv Ltd <DRP A/C> 588,343 0.45%
Mr Alister John Hodges 588,235 0.45%
Ms Danielle Marie Tomisich 588,235 0.45%
BNP Paribas Noms(Nz) Ltd<Drp> 585,268 0.45%
Investment Holdings Pty Ltd <Investment Holdings Unit A/C> 500,000 0.39%
BNP Paribas Noms Pty Ltd <Drp> 436,662 0.34%
Telunapa Pty Ltd <Telunapa Capital A/C> 394,118 0.30%
Mjc Pty Limited <The Michael Crouch Fam A/C> 390,936 0.30%
Netwealth Investments Limited <Wrap Services A/C> 367,080 0.28%
Zen Ventures Pty Ltd <Zen Ventures A/C> 264,705 0.20%
BNP Paribas Nominees Pty Ltd <Ioof Insmt Mgmt Ltd Drp> 250,000 0.19%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 556 493 350 447 37 1,883

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
Australiansuper Pty Ltd 30/12/2021 7,259,742 5.39
Tomisich Family Pty Ltd 30/12/2021 76,470,588 56.82

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
30-12-21 Australiansuper Pty Ltd 1,081,435 6.44 5.39

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2021 $2.29 30 June
TRJ Historical Price Data (CSV)
Up to 20 years of EOD share price history
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.